Trh Financial, LLC Pfizer Inc Transaction History

Trh Financial, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$46.53 - $55.17 $182,955 - $216,928	-3,932 Closed	0 $0
Q1 2022 Apr 11, 2022	BUY	$45.75 - $56.69 $1,006 - $1,247	22 Added 0.56%	3,932 $204,000
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $161,561 - $239,487	3,910 New	3,910 $231,000
Q3 2021 Oct 18, 2021	SELL	$39.25 - $50.42 $213,520 - $274,284	-5,440 Closed	0 $0
Q2 2021 Jul 16, 2021	SELL	$35.91 - $40.68 $24,239 - $27,459	-675 Reduced 11.04%	5,440 $213,000

Q1 2021 Apr 12, 2021	BUY	$33.49 - $37.77 $7,669 - $8,649	229 Added 3.89%	6,115 $222,000
Q4 2020 Jan 20, 2021	SELL	$33.47 - $42.56 $3,715 - $4,724	-111 Reduced 1.85%	5,886 $217,000
Q3 2020 Oct 14, 2020	BUY	$31.75 - $37.25 $190,404 - $223,388	5,997 New	5,997 $220,000
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $328,488 - $398,505	-10,906 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $359,025 - $407,448	10,906 New	10,906 $423,000

3,158

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $155B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Trh Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Trh Financial, LLC with notifications on news.